December 18th, 2013 | 
Author: Researchers from Aker BioMarine Antarctic AS have announced the acceptance of a new study on Superba(TM) Krill oil in the journal Nutrition Research. The study is scheduled for publication in early 2014.
The study investigated the effects of Superba(TM) Krill on blood lipids in subjects with borderline high or high triglyceride levels. In terms of design, a total of 300 volunteers were divided into five groups and supplemented with krill oil at either 0.5, 1, 2 or 4 grams per day or placebo (olive oil). The subjects included in the study had blood triglyceride values between 150 and 499 mg/dL. Blood lipids were measured at baseline, 6 weeks and 12 weeks of treatment.
Study coordinator Kjetil Berge, PhD, R&D Director, Aker BioMarine Antarctic, commented: “This is exciting because it is the biggest krill study conducted in humans to date. We look forward to sharing the full results in the coming weeks.”
Tove Flem Jacobsen, Vice President of R&D and Regulatory Affairs, Aker BioMarine Antarctic added: “This study helps further document the health benefits of phospholipid-bound EPA and DHA from krill and represents an important addition to our growing research portfolio.”
Aker BioMarine is a krill ingredient company that is primary in its supply. Its proprietary Eco-Harvesting® technology and on-board processing result in the unique composition of Superba(TM) Krill oil and provides 100% traceability from sea to shelf. The Marine Stewardship Council (MSC) has granted MSC Certification to Aker’s fisheries, which is an exclusive distinction that no other krill fishery has earned. As part of an established commitment to substantiating krill’s health benefits, Aker continues to sponsor in vitro, in vivo, and human clinical trials with phospholipid EPA and DHA from krill oil, consistently demonstrating a higher uptake of phospholipid omega-3 fatty acids, improved blood lipid profiles, and increased uptake of DHA in brain tissue compared to other marine omega-3 fatty acid sources.
Reference: Berge, K. et al., “Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride levels.” Paper Accepted in Nutrition Research, December 2013.
About SuperbaTM Krill
SuperbaTM Krill is a pure, natural source of the health-promoting EPA & DHA omega-3 essential fatty acids and the naturally occurring antioxidant astaxanthin. The uniqueness of SuperbaTM Krill Oil is that the omega-3 fatty acids are provided in phospholipid form. In vitro, in vivo and human clinical research has demonstrated the safety and efficacy of SuperbaTM Krill Oil.
About Aker BioMarine
Aker BioMarine is an integrated biotechnology company dedicated to the sustainable harvesting of krill and development of krill-derived biotech products. The company supplies biomarine ingredients through an optimized value chain from raw materials to customers. Aker BioMarine’s SuperbaTM Krill products are provided with 100% traceability from sea to shelf. Only Aker’s krill fishery has been awarded Marine Stewardship Council (MSC) Certification.
For more information, please contact:
Matts Johansen, COO, Aker BioMarine, +47 916 30 120
North America:
Todd Norton, +1 206-855-6736 x 215
Europe:
Roar Hernes, +47 (241) 30123
Asia:
Chris McReynolds, +1 206-660-6756
chris.mcreynolds@akerbiomarine.com
Australia:
Lalen Dogan, +61-3-9999-1112
Posted in Association News
